Agilent Technologies Inc (A)
137.49
-1.71
(-1.23%)
USD |
NYSE |
Apr 24, 16:00
137.42
-0.07
(-0.05%)
Pre-Market: 20:00
Agilent Technologies Enterprise Value: 41.10B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 41.10B |
| April 23, 2024 | 41.60B |
| April 22, 2024 | 40.05B |
| April 19, 2024 | 39.70B |
| April 18, 2024 | 39.62B |
| April 17, 2024 | 40.24B |
| April 16, 2024 | 40.90B |
| April 15, 2024 | 41.90B |
| April 12, 2024 | 42.05B |
| April 11, 2024 | 43.30B |
| April 10, 2024 | 43.05B |
| April 09, 2024 | 44.00B |
| April 08, 2024 | 43.14B |
| April 05, 2024 | 43.04B |
| April 04, 2024 | 42.23B |
| April 03, 2024 | 42.93B |
| April 02, 2024 | 43.06B |
| April 01, 2024 | 43.46B |
| March 28, 2024 | 43.45B |
| March 27, 2024 | 43.99B |
| March 26, 2024 | 43.13B |
| March 25, 2024 | 43.46B |
| March 22, 2024 | 44.02B |
| March 21, 2024 | 44.40B |
| March 20, 2024 | 43.97B |
| Date | Value |
|---|---|
| March 19, 2024 | 44.00B |
| March 18, 2024 | 43.62B |
| March 15, 2024 | 44.03B |
| March 14, 2024 | 43.36B |
| March 13, 2024 | 44.13B |
| March 12, 2024 | 44.13B |
| March 11, 2024 | 43.97B |
| March 08, 2024 | 44.14B |
| March 07, 2024 | 44.56B |
| March 06, 2024 | 43.66B |
| March 05, 2024 | 43.11B |
| March 04, 2024 | 42.67B |
| March 01, 2024 | 41.56B |
| February 29, 2024 | 41.06B |
| February 28, 2024 | 40.96B |
| February 27, 2024 | 39.65B |
| February 26, 2024 | 39.34B |
| February 23, 2024 | 39.50B |
| February 22, 2024 | 39.49B |
| February 21, 2024 | 40.46B |
| February 20, 2024 | 40.12B |
| February 16, 2024 | 40.32B |
| February 15, 2024 | 40.29B |
| February 14, 2024 | 39.56B |
| February 13, 2024 | 38.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
20.37B
Minimum
Aug 14 2019
55.70B
Maximum
Sep 03 2021
36.86B
Average
38.64B
Median
Enterprise Value Benchmarks
| Bio-Rad Laboratories Inc | 7.527B |
| Revvity Inc | 14.98B |
| Bruker Corp | 12.15B |
| Azenta Inc | 1.921B |
| Harvard Bioscience Inc | 192.42M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 348.00M |
| Revenue (Quarterly) | 1.658B |
| Total Expenses (Quarterly) | 1.274B |
| EPS Diluted (Quarterly) | 1.18 |
| Gross Profit Margin (Quarterly) | 54.76% |
| Profit Margin (Quarterly) | 20.99% |
| Earnings Yield | 3.05% |
| Operating Earnings Yield | 3.22% |
| Normalized Earnings Yield | 3.055 |